Opthea | OPT - Des Atouts



Des Atouts Changement Date
Cochlear AUD 2.79B 31.3M 2025-12
CSL USD 37.9B 1.5B 2025-12
Fisher & Paykel Healthcare NZD 2.63B 80.5M 2025-12
Medical Developments International AUD 63.57M 2.83M 2025-12
Nanosonics AUD 279.25M 6.77M 2025-12
Neuren Pharmaceuticals AUD 342.86M 11.61M 2025-12
Pacific Edge NZD 34.66M 2.37M 2025-12
Pacific Smiles AUD 163.53M 8.45M 2025-12
Paradigm Biopharmaceuticals AUD 23.15M 1.42M 2025-12
PYC Therapeutics AUD 159.13M 24.15M 2025-12
Ramsay Health Care AUD 21.7B 777.8M 2025-12
ResMed USD 8.5B 195.02M 2025-12
Telix Pharmaceuticals AUD 1.16B 25.97M 2025-12